Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Cold-pressed rapeseed oil is most resistant to oxidation and certain oils may reduce chronic disease risk; consumers like the taste of pumpkin oil best.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib helped regrow hair in most patients with severe hair loss.

RDW can be a useful marker for inflammation in alopecia areata patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.